Although hysterectomy remains the most common procedure for treating fibroids and fibroids are the leading indication for ...

A 40-year-old Human Resources Manager, Bisi, with uterine fibroids, delayed her treatment for over  four years for fear of ...

The presence of fibroids made it difficult for her ovaries to be seen and accessed for egg retrieval, resulting in fewer eggs ...

Uterine fibroids are a common condition that affects up to 80% of women in their lifetime. Nearly half of those women will ...

No selective progesterone-receptor modulator has been approved in the United States for the treatment of fibroids. 22 Numerous procedures have been developed to reduce bleeding and fibroid size ...

In women with type 2 diabetes, use of GLP-1 receptor agonists was associated with a reduced risk of new-onset uterine ...

Theramex has announced that the Scottish Medicine Consortium (SMC) has recommended Yselty® for the treatment of moderate to severe symptoms of uterine fibroids (UFs) aligned to the product indication ...

Uterine fibroids are a common condition that affects up to 80% of women in their lifetime. Nearly half of those women will experience symptoms that affect their quality of life and fertility, ...

Fibroids can be difficult to address. Birth control pills are currently the preferred drug treatment. Your healthcare provider may recommend surgical removal of your fibroids, which is a procedure ...

The following is a summary of “Currently Available Treatment Modalities for Uterine Fibroids,” published in the May 2024 issue of Obstetrics & Gynecology by Micić et al. Uterine fibroids are common ...

Axicabtagene ciloleucel, known by the brand name Yescarta, has been accepted for treating adults with two types of blood cancer.